Related Experiment Video
Updated: Oct 27, 2025
07:03
Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
Published on: September 23, 2022
2.3K
Extracellular Vesicles in Regenerative Medicine: Potentials and Challenges
1Research Institute of Hyperbaric Medicine and Science, Yonsei University Wonju College of Medicine, Wonju-si, Gangwon-do, 26426, Republic of Korea.
Tissue Engineering and Regenerative Medicine
|July 23, 2021
Summary
Extracellular vesicles (EVs) show promise in regenerative medicine, offering a cell-free therapeutic approach. These nanoscale vesicles can be engineered to restore damaged tissues and organs, overcoming limitations of traditional cell therapies.
Area of Science:
- Regenerative Medicine
- Cell Biology
- Biotechnology
Background:
- Regenerative medicine aims to restore tissue and organ function.
- Extracellular vesicles (EVs) are cell-secreted nanoparticles facilitating intercellular communication.
- EVs present a promising cell-free therapeutic alternative to cell-based therapies.
Purpose of the Study:
- To explore the potential of extracellular vesicles (EVs) in regenerative medicine.
- To highlight the advantages of engineered EVs over conventional cell therapies.
- To provide an overview of current research on EV applications in tissue repair and regeneration.
Main Methods:
- Review of current scientific literature on extracellular vesicles (EVs).
- Analysis of the properties and functions of EVs in intercellular communication.
- Examination of engineering strategies for therapeutic EV modification.
Main Results:
- EVs are naturally occurring nanoscale vesicles involved in cell-to-cell communication.
- EVs can be engineered for targeted delivery and enhanced therapeutic efficacy.
- A significant increase in research publications highlights the growing importance of EVs in regenerative medicine.
Conclusions:
- Extracellular vesicles (EVs) represent a novel and versatile therapeutic platform for regenerative medicine.
- EVs offer a cell-free approach with potential to overcome challenges associated with cell therapies.
- Further research into EV engineering and application is crucial for advancing regenerative medicine strategies.
Related Concept Videos
01:36Overview of Exosomes
3.0K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.0K
01:19Clinical Applications of Epidermal Stem Cells
2.9K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.9K
01:19Mesenchymal Stem Cells
5.1K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.1K
00:57Embryonic Stem Cells
4.1K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.1K